PDT opportunities in oncology practice

Current Research on Laser Use in Oncology Pub Date : 2005-08-08 DOI:10.1117/12.640040

M. Gelfond

引用次数: 4

Abstract

The results of novel photosensitizer Photoditazine clinical trials have demonstrated high clinical potential of the drug in the PDT of 53 patients with malignant tumors. The drug has advantageous spectral, physico-chemical and energetic characteristics in comparison to currently used Russian and foreign photosensitizers.

查看原文本刊更多论文

PDT在肿瘤学实践中的机会

新型光敏剂photodiazine临床试验结果表明，该药物在53例恶性肿瘤患者的PDT中具有很高的临床潜力。与目前国内外使用的光敏剂相比，该药物具有良好的光谱、物理化学和能量特性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Current Research on Laser Use in Oncology

自引率

0.00%

发文量